As hypercalciuria, one main risk factor of renal calcifications, often occurs under standard therapy with calcium and vitamin D, treatment with parathyroid hormone is getting more important as it allows to avoid hypercalciuria. This evidence concerns the gene PTH and Hypercalciuria.